The Evaluation of Clot Waveform Analyses for Assessing Hypercoagulability in Patients Treated with Factor VIII Concentrate

Background: Regular prophylactic therapy has become an increasingly common treatment for severe hemophilia. Therefore, hypercoagulability—a potential risk factor of thrombosis—is a cause for concern in hemophilic patients treated with a high dose of FVIII concentrate. In clot waveform analysis (CWA)...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsumoto, Takeshi, Wada, Hideo, Shiraki, Katsuya, Suzuki, Kei, Yamashita, Yoshiki, Tawara, Isao, Shimpo, Hideto, Shimaoka, Motomu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10573981/
https://www.ncbi.nlm.nih.gov/pubmed/37834964
http://dx.doi.org/10.3390/jcm12196320

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10573981/
https://www.ncbi.nlm.nih.gov/pubmed/37834964
http://dx.doi.org/10.3390/jcm12196320

Ejemplares similares